Latest AI and machine learning research in neurology for healthcare professionals.
Neuroimaging faces a reproducibility crisis, where studies on small, heterogeneous datasets produce unreliable brain-wide associations and AI models that fail to generalize. To address this, we introduce GenBrain, a generative foundation model pretrained on approximately 1.2 million 3D scans from over 44,000 individuals across 34 imaging modalities to learn a population prior of brain structure an...
This study aimed to develop an artificial intelligence (AI) algorithm capable of distinguishing Alzheimer’s disease (AD) from healthy patients using gut microbiome metagenomics data. To do so, 16S rRNA gene and Whole Genome Shotgun (WGS) datasets available in the literature were utilised. Data was pre-processed and filtered. Then, an initial analysis was done to study classical parameters of micro...
Parkinson’s disease (PD) is characterized by substantial heterogeneity in progression patterns, posing major challenges for individualized prognosis a...
Cognitive impairment (CI) is often under detected in primary care due to time and resource constraints. Passive analysis of clinical dialogue may offe...
Cerebral small vessel disease (CSVD) is a leading cause of age-related cognitive decline and neurological disorders, yet its precise characterization ...
To identify clusters of high-cost patients in England based on diagnoses and sociodemographic characteristics to inform targeted population health man...
Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease of motor neurons that leads to muscle wasting, paralysis, and death, with an average lif...
Accurate prediction of neurological outcome after cardiac arrest is essential for guiding intensive care decisions. Electroencephalography (EEG) suppo...
Differentiating between motor functional dissociative seizures (FDS) and motor epileptic seizures (ES) is a common diagnostic challenge, requiring vid...
Stroke is a leading global public health challenge and the second leading cause of death worldwide. In China, its burden continues to escalate amid po...
Cerebral Palsy (CP), affecting approximately 1 in 500 children due to abnormal brain development, impacts movement control. Early risk assessment via ...
Alzheimer’s disease (AD) exhibits profound spatial heterogeneity in its molecular and pathological features, yet the basis of this regional selectivit...
Structural changes following pediatric intracerebral hemorrhage (ICH) caused by ruptured brain vascular malformations remain poorly understood. We con...
In this study, we investigated whether individual brain maps of natural frequencies derived from EEG can serve as physiologically meaningful biomarker...
The majority of causal genome-wide association studies (GWAS) variants for Alzheimer’s disease (AD) are believed to reside in noncoding regions of the...
Major depressive disorder (MDD) affects millions worldwide, yet its neurobiological underpinnings remain elusive. Neuroimaging studies have yielded in...
Mild cognitive impairment (MCI) is an intermediate stage between normal ageing and dementia, with affected individuals at a higher risk of progressing...
Parkinson’s Disease (PD) is the most prevalent neurodegenerative disorder after Alzheimer’s, yet its diagnosis largely relies on subjective clinical a...
Glaucoma, a leading cause of blindness worldwide, depends on accurate optic nerve head assessment, particularly optic disc and cup segmentation, for d...
Antidepressant use is common in people with dementia. Antidepressants may be started to manage symptoms of dementia, rather than depressive and anxiet...